ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 764

The Clinical and Angiographic Features of Chinese Takayasu’s Arteritis Patients: A Cohort Study of 591 Patients in 6 Years

Yunjiao Yang1, Jing Li 2, Xinping Tian 1 and Xiaofeng Zeng 1, 1Peking Union Medical College Hospital, Beijing, China (People's Republic), 2Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Medical College, Beijing

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Angiography and angiitis, Clinical, Takayasu arteritis

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Sunday, November 10, 2019

Session Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I: Takayasu's Arteritis & Polymyalgia Rheumatica

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: To investigate the clinical and angiographic features of 591 Chinese Takayasu’s arteritis (TAK) patients

Methods: Clinical and angiographic findings of 591 Chinese TAK patients enrolled in the Chinese Registry for Systemic Vasculitis (CRSV) from 2013 to October 31 of 2018 were collected. The vascular involvement were analyzed by Dendrogram using Ward Linkage. 

Results: Clinical manifestations included Systemic manifestation in 66.2%, mucocutaneous abnormalities in 15.2% , sign and symptoms of peripheral vessels in 92.9%(as showed in Figure 1), abnormalities of central nervous system in 57.2%(56 patients suffered from stroke ), vision loss in 11.2%,hypertension in 46.1% and abnormalities of renal arteries in 35.5% of the patients. Meanwhile,28.1% of patients underwent angioplasty during the course of disease. The clustering analysis of arterial involvement was showed in figure 2.

Conclusion: The clinical and angiographic findings of TAK patients in China were different to those reported from other countries. We should pay more attention to the uniqueness of Chinese patients with Takayasu arteritis.

Figure 1:Sign and symptoms of peripheral vessels

Figure 2:The clustering analysis of arterial involvement


Disclosure: Y. Yang, None; J. Li, None; X. Tian, None; X. Zeng, None.

To cite this abstract in AMA style:

Yang Y, Li J, Tian X, Zeng X. The Clinical and Angiographic Features of Chinese Takayasu’s Arteritis Patients: A Cohort Study of 591 Patients in 6 Years [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-clinical-and-angiographic-features-of-chinese-takayasus-arteritis-patients-a-cohort-study-of-591-patients-in-6-years/. Accessed December 10, 2019.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-clinical-and-angiographic-features-of-chinese-takayasus-arteritis-patients-a-cohort-study-of-591-patients-in-6-years/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Atlanta, Georgia

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.